Thomas Gajewski, MD

Professor of Medicine

Gajewski

Thomas Gajewski, MD, PhD, investigates and develops new treatments for patients with melanoma. He has a special interest in the development of immunotherapies against this disease. Dr. Gajewski also leads development of immune-based therapies for other cancers, using new laboratory data on how the immune system is regulated to develop novel clinical trials.

Dr. Gajewski serves as an editor for Cancer Research and Journal for Immunotherapy of Cancer. In addition, he is immediate past president of the Society for Immunotherapy of Cancer and has served on the program committees for the American Society for Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).

Practice Locations

The University of Chicago Medicine 
5841 S. Maryland Avenue 
Chicago, IL 60637

Duchossois Center for Advanced Medicine 
5758 S. Maryland Avenue 
Chicago, IL 60637

Year Started Practice

1993

Board Certification

Medical Oncology

Medical School

The University of Chicago Pritzker School of Medicine

Internship, Residency and Fellowship

The University of Chicago Medicine

Memberships

American Association of Cancer Research 
American Association of Immunologists 
American Society of Clinical Oncology 
Society for Immunotherapy of Cancer

Related Videos

Overcoming Immunotherapy Resistance Pathways in the Tumor Microenvironment Video

Overcoming Immunotherapy Resistance Pathways in the Tumor Microenvironment

Dr. Thomas F. Gajewski, professor of medicine, explains why T cell-inflamed tumor microenvironment may serve as a predictive biomarker for response to immunotherapies. Dr. Gajewski also describes how STING agonists may provide means to ...